|
MedChem 2011 - Emerging Targets and Treatments:
Opportunities and Challenges for Drug Design |
| Confirmed Plenary lectures |
| | Translocator Protein as a Promising Target for Novel Anxiolytics |
Prof. Federico DA SETTIMO
(UNIVERSITÀ DI PISA, Pisa, Italy) |
|
| | Drug-to-Genome-to-Drug: Discovery and Optimisation of an Antimalarial Compound |
Prof. Benoit DEPREZ
(UNIVERSITY OF LILLE 2, Lille, France) |
|
| | New Selective Androgen Receptor Modulators (SARM) for the Treatment of Cachexia |
Dr Pierre DEPREZ
(GALAPAGOS, Romainville, France) |
|
| | Therapeutic Targeting of TLR Signalling |
Dr Brian KEOGH
(OPSONA THERAPEUTICS LTD, Dublin 8, Ireland) |
|
| | Targeting GSK-3 with ATP Non-Competitive Inhibitors: From the Bench to the Clinical Trials |
Prof. Ana MARTINEZ
(INSTITUTO DE QUIMICA MEDICA-CSIC, Madrid, Spain) |
|
| | New Targets for the Treatment of HIV |
Dr David PRYDE
(PFIZER GLOBAL R&D, Sandwich, United Kingdom) |
|
| Confirmed Oral Communications |
| | Can Medicinal Chemistry Solve Target Related Issues? |
Dr Sandro BOLAND
(AMAKEM NV, Diepenbeek, Belgium) |
|
| | Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Discovery of an Orally Active TDO Inhibitor |
Prof. Raphaël FREDERICK
(UCLOUVAIN, Bruxelles-Woluwé, Belgium) |
|
| | MASPIT, a Strategy for Small Molecule-Protein Interaction Mapping in Intact Human Cells |
Dr Sam LIEVENS
(UGENT/VIB, Gent, Belgium) |
|
| <Previous page |
.jpg){kind=small}